Bortezomib-based four-drug combination regimen improved the efficacy of multiple myeloma patients receiving previous doublet or triplet regimens containing Bortezomib.
10.3760/cma.j.issn.0253-2727.2015.09.017
- VernacularTitle:BDDT方案对硼替佐米治疗原发耐药或疗效不佳的多发性骨髓瘤患者的临床疗效分析
- Author:
Junru LIU
1
;
Juan LI
1
;
Dong ZHENG
1
Author Information
1. Department of Hematology, The First Affiliated Hospital, Sun Yat- sen University, Guangzhou 510080, China.
- Publication Type:Journal Article
- MeSH:
Bortezomib;
therapeutic use;
Drug Combinations;
Humans;
Multiple Myeloma;
drug therapy
- From:
Chinese Journal of Hematology
2015;36(9):793-795
- CountryChina
- Language:Chinese
